21 November 2017
News and Views
Links and Services
The most recent issue of Gastroenterology investigates safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.
The IMAgINE 1 study evaluated the safety and efficacy of adalimumab double-blind maintenance dosi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors